US Computer-Aided Detection (CAD) Market – Insights
Computer-aided detection (CAD) software constitutes a set of algorithms, which use pattern recognition method predominantly to aid radiologists in detecting potentially diseased lesions or regions in the human body. It is widely used in breast cancer detection. It is also used in the diagnosis of lung cancer, colon cancer, prostate cancer, bone metastases, coronary artery disease, congenital heart defect, pathological brain detection, Alzheimer's disease, and diabetic retinopathy.
U.S. computer-aided detection (CAD) market is estimated to account for US$ 679.9 Mn in terms of value by the end of 2027.
U.S. Computer-Aided Detection (CAD) Market: Drivers
Increasing prevalence of breast cancer is expected to propel growth of the U.S. computer-aided detection (CAD) market over the forecast period. For instance, according to Breastcancer.org, in 2019, an estimated 268,600 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S.
Moreover, increasing adoption of CAD among radiologists is also expected to propel growth of the market. Use of CAD can help to reduce the false negative rate and increase the detection of breast cancer, particularly early breast cancer, which is expected to further boost its adoption.
Breast CAD Computer-Aided Detection (CAD) held dominant position in the U.S. computer-aided detection (CAD) market in 2019, accounting for 71.9% share in terms of value, followed by Chest Computer-Aided Detection (CAD).
Figure 1. U.S. Computer-Aided Detection (CAD) Market Share (%), by Product Type, 2019
U.S. Computer-Aided Detection (CAD) Market: Restraints
Inadequate reimbursement policies related to CAD is expected to hinder growth of the U.S. computer-aided detection (CAD) market. Majority of medical insurance companies do not offer reimbursement for procedures using CAD, which has led to use of alternate methods such as pathological test, biopsy, mammography, or MRI.
Moreover, lack of trained radiologist and technicians is also expected to hamper growth of the market.
U.S. Computer-Aided Detection (CAD) Market: Opportunities
Development of single packaged software solution for multiple applications is expected to offer lucrative growth opportunities for players in the U.S. computer-aided detection (CAD) market. Majority of software available in the market can assess images from one modality for specific indication. Key players can focus on introducing a single software that is capable of examining images from different modalities for several indications. Such approach would reduce the cost of products and services related to CAD.
More flexibility in licensing and renewal process of CAD software is also expected to fuel growth of the market. Majority of market players offer a one-year license agreement, which can be renewed for another year by paying 70% of the actual cost. However, extending the licensing period and decreasing the renewal cost is expected to increase demand for CAD.
Chest Computer-Aided Detection (CAD) segment in the U.S. computer-aided detection (CAD) market was valued at US$ 66.1 Mn in 2019 and is expected to reach US$ 86.4 Mn by 2027 at a CAGR of 3.1% during the forecast period.
Market Trends/Key Takeaways
The market is witnessing increasing use of digital mammography instead of film screen as digital mammography offers high sensitivity in women with dense breasts. Moreover, the use of digital breast tomosynthesis is also increasing, in which multiple low-dose mammographic images are acquired of compressed breast from multiple angles.
The use of Artificial intelligence (AI) in CAD has proven to enhance the efficiency and accuracy of an advanced imaging technology used to screen for breast cancer. Use of AI also increases the sensitivity and specificity of CAD. It can also decrease the recall rate for non-cancers, or the rate at which women were called back for follow-up examinations based on benign findings and the reading time.
U.S. Computer-Aided Detection (CAD) Market: Competitive Landscape
Major players operating in the U.S. computer-aided detection (CAD) market include, iCAD, Inc., Koninklijke Philips N.V, Hologic, Inc., Carestream Health, Inc., ScreenPoint Medical BV, Siemens AG, GE Healthcare, EDDA Technology, Inc., Qlarity Imaging, and Fujifilm Holdings Corporation.
U.S. Computer-Aided Detection (CAD) Market: Key Developments
Key players in the market are focused on product commercialization through various platforms to enhance their market share. For instance, in December 2019, iCAD, Inc. announced that its Breast Health Solutions suite, which includes ProFound AI for Digital Breast Tomosynthesis (DBT), will be available on the Nuance AI Marketplace.
Key players in the market are focused on expanding their product and service portfolio. For instance, in November 2019, Qlarity Imaging, a developer of computer-aided breast cancer diagnostic system, announced to introduce complementary software to support radiologists in MRI-guided procedures.